Diovan Comp 160 mg/12,5 mg 160 mg+12,5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan comp 160 mg/12,5 mg 160 mg+12,5 mg filmovertrukne tabletter

novartis healthcare a/s - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160 mg+12,5 mg

Diovan Comp 160 mg/25 mg 160 mg+25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan comp 160 mg/25 mg 160 mg+25 mg filmovertrukne tabletter

novartis healthcare a/s - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160 mg+25 mg

Diovan Comp 320 mg/12,5 mg 320 mg+12,5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan comp 320 mg/12,5 mg 320 mg+12,5 mg filmovertrukne tabletter

novartis healthcare a/s - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 320 mg+12,5 mg

Diovan Comp 320 mg/25 mg 320 mg+25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan comp 320 mg/25 mg 320 mg+25 mg filmovertrukne tabletter

novartis healthcare a/s - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 320 mg+25 mg

Diovan Comp 80 mg/12,5 mg 80 mg+12,5 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

diovan comp 80 mg/12,5 mg 80 mg+12,5 mg filmovertrukne tabletter

novartis healthcare a/s - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 80 mg+12,5 mg

Entresto Den Europæiske Union - dansk - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis Den Europæiske Union - dansk - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Amlodipine/Valsartan/Hydrochlorothiazide "Krka" 10+160+25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

amlodipine/valsartan/hydrochlorothiazide "krka" 10+160+25 mg filmovertrukne tabletter

krka d.d. novo mesto - amlodipinbesilat, hydrochlorthiazid, valsartan - filmovertrukne tabletter - 10+160+25 mg